Literature DB >> 15123501

Global burden of depressive disorders in the year 2000.

T B Ustün1, J L Ayuso-Mateos, S Chatterji, C Mathers, C J L Murray.   

Abstract

BACKGROUND: The initial Global Burden of Disease study found that depression was the fourth leading cause of disease burden, accounting for 3.7% of total disability adjusted life years (DALYs) in the world in 1990. AIMS: To present the new estimates of depression burden for the year 2000.
METHOD: DALYs for depressive disorders in each world region were calculated, based on new estimates of mortality, prevalence, incidence, average age at onset, duration and disability severity.
RESULTS: Depression is the fourth leading cause of disease burden, accounting for 4.4% of total DALYs in the year 2000, and it causes the largest amount of non-fatal burden, accounting for almost 12% of all total years lived with disability worldwide.
CONCLUSIONS: These data on the burden of depression worldwide represent a major public health problem that affects patients and society.

Entities:  

Mesh:

Year:  2004        PMID: 15123501     DOI: 10.1192/bjp.184.5.386

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  424 in total

1.  A proposed model for economic evaluations of major depressive disorder.

Authors:  Hossein Haji Ali Afzali; Jonathan Karnon; Jodi Gray
Journal:  Eur J Health Econ       Date:  2011-06-02

Review 2.  The costs of depression.

Authors:  Ronald C Kessler
Journal:  Psychiatr Clin North Am       Date:  2011-12-16

3.  Bipolar spectrum disorders in primary care: optimising diagnosis and treatment.

Authors:  Daniel J Smith; Ajay Thapar; Sharon Simpson
Journal:  Br J Gen Pract       Date:  2010-05       Impact factor: 5.386

4.  Biological research into depression: a clinician's commentary.

Authors:  Jules Angst
Journal:  World Psychiatry       Date:  2010-10       Impact factor: 49.548

5.  Change in level of positive mental health as a predictor of future risk of mental illness.

Authors:  Corey L M Keyes; Satvinder S Dhingra; Eduardo J Simoes
Journal:  Am J Public Health       Date:  2010-10-21       Impact factor: 9.308

6.  Psychosocial working conditions and depressive symptoms among Swedish employees.

Authors:  Linda L Magnusson Hanson; Töres Theorell; Per Bech; Reiner Rugulies; Hermann Burr; Martin Hyde; Gabriel Oxenstierna; Hugo Westerlund
Journal:  Int Arch Occup Environ Health       Date:  2009-02-24       Impact factor: 3.015

Review 7.  Duloxetine: a review of its use in the treatment of major depressive disorder.

Authors:  James E Frampton; Greg L Plosker
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

8.  Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States.

Authors:  Katherine M Keyes; Keely Cheslack-Postava; Carolyn Westhoff; Christine M Heim; Michelle Haloossim; Kate Walsh; Karestan Koenen
Journal:  Am J Epidemiol       Date:  2013-09-15       Impact factor: 4.897

9.  Modulation of motor cortex excitability predicts antidepressant response to prefrontal cortex repetitive transcranial magnetic stimulation.

Authors:  Albino J Oliveira-Maia; Daniel Press; Alvaro Pascual-Leone
Journal:  Brain Stimul       Date:  2017-03-31       Impact factor: 8.955

10.  The role of bullying in depressive symptoms from adolescence to emerging adulthood: A growth mixture model.

Authors:  Ryan M Hill; William Mellick; Jeff R Temple; Carla Sharp
Journal:  J Affect Disord       Date:  2016-09-19       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.